Dr. Yanlei Ma 马延磊
Chief Physician
Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of colorectal tumors, including minimally invasive laparoscopic surgery and sphincter-preserving radical surgery for low rectal cancer. Focuses on early diagnosis, prevention, young-onset colorectal cancer, familial polyposis, and polyp cancerization intervention.
Dr. Ma is Chief Physician and Deputy Director of the Second Colorectal Surgery Department at Fudan University Shanghai Cancer Center. Holding a PhD from Shanghai Jiao Tong University School of Medicine, Dr. Ma has over ten years of experience in colorectal surgery and completed fellowships at UNMC and MD Anderson Cancer Center. Research honors include the Shanghai Science and Technology Progress Award.
Professional roles
- Standing Committee Member, Gastrointestinal Tumor Laparoscopy Professional Committee, Shanghai Anti-Cancer Association
- Member, Youth Council, China Anti-Cancer Association
- Member, Youth Expert Committee, Chinese Society of Clinical Oncology (CSCO)
- Member, Tumor Heterogeneity and Individualized Treatment Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Ma Yanlei). Papers usually list the name as Yanlei Ma or Ma Y.
Selected publications
63 papers on PubMed matched by name and affiliation; 25 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cell Discov, 2026 (senior author): Eggerthella lenta disrupts the gut vascular barrier to drive colorectal cancer liver metastasis. PubMed 42768024
- Gastroenterology, 2026 (senior author): Revealing the Antagonistic Interactions of Faecalibacterium prausnitzii and Bacteroides fragilis in Colorectal Cancer. PubMed 41790075
- Lancet Oncol, 2025 (senior author): Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study. PubMed 40617240
- Cell Rep Med, 2025 (senior author): Perioperative administration of CBM588 in colorectal cancer radical surgery: A single-center, randomized controlled trial. PubMed 40633539
- Adv Sci (Weinh), 2025 (senior author): Enabling Targeted Drug Delivery for Treatment of Ulcerative Colitis with Mucosal-Adhesive Photoreactive Hydrogel. PubMed 39900372
- J Clin Invest, 2025 (senior author): Fusobacterium nucleatum promotes colorectal cancer through neogenesis of tumor stem cells. PubMed 39656543
- Microbiome, 2024 (senior author): Distinct microbes, metabolites, and the host genome define the multi-omics profiles in right-sided and left-sided colon cancer. PubMed 39731152
- MedComm (2020), 2024 (senior author): Organoids in gastrointestinal diseases: from bench to clinic. PubMed 38948115
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion